Bettzy Stephen

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0003-1653-2012

MedicineBiochemistry, Genetics and Molecular BiologyEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Phase 2 study of pembrolizumab in patients with advanced rare cancers”.

Phase 2 study of pembrolizumab in patients with advanced rare cancers

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000347

N/A

4.0DataRank · unranked

131 citations

Funda Meric‐Bernstam, Bettzy Stephen, Daniel D. Karp, Joud Hajjar, Jordi Rodon Ahnert +35 more

Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004822

N/A

1.4DataRank · unranked

44 citations

Bettzy Stephen, Daniel D. Karp, Sarina A. Piha‐Paul, David S. Hong, D Jain +10 more

The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial

Investigational New Drugs(2021)10.1007/s10637-020-01043-9

N/A

1.1DataRank · unranked

25 citations

Amir A. Jazaeri, Shannon N. Westin, Anil K. Sood, Lois M. Ramondetta, Mingxuan Xu +8 more

Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000665

N/A

0.821DataRank · unranked

12 citations

Phyu P. Aung, Sinchita Roy‐Chowdhuri, Mingxuan Xu, Fengying Ouyang, Anas Alshawa +11 more

Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non–small cell lung cancer

Cancer(2023)10.1002/cncr.34820

N/A

0.488DataRank · unranked

9 citations

Janet Tu, Denái R. Milton, Bülent Yılmaz, Yanyan Tian, Frank V. Fossella +8 more

Phase I study of sapanisertib (CB‐228/TAK‐228/MLN0128) in combination with ziv‐aflibercept in patients with advanced solid tumors

Cancer Medicine(2024)10.1002/cam4.6877

N/A

0.418DataRank · unranked

8 citations

Bettzy Stephen, Siqing Fu, Daniel D. Karp, Vivek Subbiah, Jordi Rodon Ahnert +8 more

Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial

Scientific Reports(2022)10.1038/s41598-022-16588-3

N/A

0.375DataRank · unranked

4 citations

David S. Hong, Christine B. Peterson, Bettzy Stephen, Ecaterina E. Dumbrava, Shubbam Pant +18 more

A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer

Gynecologic Oncology(2025)10.1016/j.ygyno.2024.12.019

N/A

0.343DataRank · unranked

7 citations

Bettzy Stephen, Muhammad Rizwan Khawaja, Yali Yang, Israa Salih, Elizve Barrientos-Toro +11 more

A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma

Cancer Medicine(2025)10.1002/cam4.70280

N/A

0.212DataRank · unranked

3 citations

Mohamed A. Gouda, Denái R. Milton, Hassan Ahmed Momin, Bülent Yılmaz, Bettzy Stephen +16 more

Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial

Journal of Immunotherapy and Precision Oncology(2025)10.36401/jipo-24-27

N/A

0.179DataRank · unranked

2 citations

Camila Bragança Xavier, Bettzy Stephen, Jeffrey How, Justin T. Moyers, Vivek Subbiah +3 more

Selinexor (KPT-330) in Combination with Immune Checkpoint Inhibition in Uveal Melanoma: A Phase 1B Trial

Journal of Immunotherapy and Precision Oncology(2025)10.36401/jipo-24-10

N/A

0.165DataRank · unranked

2 citations

Abdulrazzak Zarifa, Yali Yang, Bettzy Stephen, Serdar A. Gurses, Ashabari Sprenger +6 more

Phase 2 study of monotherapy with pembrolizumab for advanced adrenocortical carcinoma

Endocrine Abstracts(2025)10.1530/endoabs.107.006

N/A

0DataRank · unranked

0 citations

Bettzy Stephen, Juhee Song, Vania Balderrama-Brondani, Feyza Yaylaci, Matthew T. Campbell +2 more

Author response to Cunha et al

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003299

N/A

0DataRank · unranked

5 citations

Christian Rolfo, Murat Ak, Mira Ayoub, Sara Ahmed, Nabil Elshafeey +13 more

532 A phase 1 dose escalation and dose expansion trial of NP-101 in patients with advanced solid tumors

Regular and Young Investigator Award Abstracts(2025)10.1136/jitc-2025-sitc2025.0532

N/A

0DataRank · unranked

0 citations

Bettzy Stephen, Serdar A. Gurses, Michelle York Gocio, Mohamed Omar Kaseb, Yali Yang +18 more

Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial

Scientific Reports(2021)10.1038/s41598-021-83317-7

N/A

0DataRank · unranked

35 citations

Amir A. Jazaeri, Pamela T. Soliman, Nicole D. Fleming, Jing Gong, Sarina A. Piha‐Paul +4 more

Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies

Cancer(2023)10.1002/cncr.35063

N/A

0DataRank · unranked

17 citations

Jibran Ahmed, Bettzy Stephen, Sarina A. Piha‐Paul, Daniel D. Karp, Abdulrazzak Zarifa +13 more

Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001752

N/A

0DataRank · unranked

54 citations

Christian Rolfo, Murat Ak, Mira Ayoub, Sara Ahmed, Nabil Elshafeey +13 more

584 Phase I/II study to evaluate the safety and tolerability of avelumab in combination with other anti-cancer therapies in patients with advanced malignancies

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0584

N/A

0DataRank · unranked

0 citations

Anne Knisely, Bettzy Stephen, Yali Yang, Juhee Song, Anas Alshawa +9 more

A phase 2 basket study of talabostat, a small‐molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers

Cancer(2025)10.1002/cncr.35728

N/A

0DataRank · unranked

4 citations

Filip Janku, Daniel D. Karp, Sarina A. Piha‐Paul, Apostolia M. Tsimberidou, Timothy A. Yap +8 more